Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Health Catalyst, Inc. Director's Dealing 2021

Dec 15, 2021

33681_dirs_2021-12-15_323550d7-dc05-406c-80ee-94842ac00e48.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Health Catalyst, Inc. (HCAT)
CIK: 0001636422
Period of Report: 2021-12-13

Reporting Person: Nelli James Patrick Jr. (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-12-13 Common Stock M 3036.00 $10.66 Acquired 118962.00 Direct
2021-12-13 Common Stock M 6500.00 $10.60 Acquired 125462.00 Direct
2021-12-13 Common Stock M 15464.00 $9.24 Acquired 140926.00 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-12-13 Stock Option (Right to Buy) $10.66 M 3036.00 Disposed 2027-04-27 Common Stock (3036.00) Direct
2021-12-13 Stock Option (Right to Buy) $10.60 M 6500.00 Disposed 2026-10-14 Common Stock (6500.00) Direct
2021-12-13 Stock Option (Right to Buy) $9.24 M 15464.00 Disposed 2025-02-10 Common Stock (15464.00) Direct

Footnotes

F1: 25% of the 15,087 shares underlying the option vested in an annual installment and the remaining balance vested in equal monthly installments until the option vested in full on April 27, 2021.

F2: 25% of the 6,500 shares underlying the option vested in an annual installment and the remaining balance vested in equal monthly installments until the option vested in full on October 14, 2020.

F3: 25% of the 18,500 shares underlying the option vested in an annual installment and the remaining balance vested in equal monthly installments until the option vested in full on February 10, 2019.